These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


403 related items for PubMed ID: 2027298

  • 1. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
    Terstappen LW, Könemann S, Safford M, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wörmann B.
    Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M, Wimazal F, Simonitsch I, Sperr WR, Mayerhofer M, Sillaber C, Hauswirth AW, Gadner H, Chott A, Horny HP, Lechner K, Valent P.
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [Abstract] [Full Text] [Related]

  • 3. [Cytomorphology of acute mixed leukemia].
    Sucić M, Batinić D, Zadro R, Mrsić S, Labar B.
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [Abstract] [Full Text] [Related]

  • 4. Analysis of acute myeloid leukemia cells by flow cytometry, introducing a new light-scattering classification.
    Harada N, Okamura S, Kubota A, Shimoda K, Ikematsu W, Kondo S, Harada M, Niho Y.
    J Cancer Res Clin Oncol; 1994 Oct; 120(9):553-7. PubMed ID: 8045921
    [Abstract] [Full Text] [Related]

  • 5. Role of FAB classification of acute leukemias in era of immunophenotyping.
    Sachdeva MU, Ahluwalia J, Das R, Varma N, Garewal G.
    Indian J Pathol Microbiol; 2006 Oct; 49(4):524-7. PubMed ID: 17183842
    [Abstract] [Full Text] [Related]

  • 6. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA.
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [Abstract] [Full Text] [Related]

  • 7. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
    Drach J, Drach D, Glassl H, Gattringer C, Huber H.
    Cytometry; 1992 Feb; 13(8):893-901. PubMed ID: 1459006
    [Abstract] [Full Text] [Related]

  • 8. Frequency of fab subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi.
    Harani MS, Adil SN, Shaikh MU, Kakepoto GN, Khurshid M.
    J Ayub Med Coll Abbottabad; 2005 Feb; 17(1):26-9. PubMed ID: 15929522
    [Abstract] [Full Text] [Related]

  • 9. [Multi-parametric analysis for leukemic immunophenotyping].
    Ujiie M, Sonoda A, Todoroki T, Amano H, Uchida T, Kawai Y, Watanabe K.
    Rinsho Byori; 1998 Nov; 46(11):1163-7. PubMed ID: 9868303
    [Abstract] [Full Text] [Related]

  • 10. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Nov; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 11. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI.
    Cancer Res; 2001 Jun 01; 61(11):4483-9. PubMed ID: 11389079
    [Abstract] [Full Text] [Related]

  • 12. Acute myeloid leukemia, FAB M-1 microgranular variant: a multiparameter study.
    Nguyen D, Brynes RK, Macaulay L, Kaplan B, Pinter-Brown LC.
    Hematol Pathol; 1989 Jun 01; 3(1):11-22. PubMed ID: 2545666
    [Abstract] [Full Text] [Related]

  • 13. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F, Latorraca A, Moretti S, Castagnari B, Ferrari L, Castoldi G.
    Cytometry; 1997 Jun 15; 30(3):134-44. PubMed ID: 9222099
    [Abstract] [Full Text] [Related]

  • 14. Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.
    Soni M, Brody J, Allen SL, Schulman P, Kolitz J, Rai K, Broome JD, Koduru PR.
    Leukemia; 1996 Apr 15; 10(4):619-23. PubMed ID: 8618437
    [Abstract] [Full Text] [Related]

  • 15. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA, Sawadogo D, Mizero L, Salou M, Karim N, Sangaré A.
    Bull Soc Pathol Exot; 2004 Apr 15; 97(5):319-22. PubMed ID: 15787262
    [Abstract] [Full Text] [Related]

  • 16. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I, Beason K, Yu C, Hughson M.
    Cancer Genet Cytogenet; 2005 Nov 15; 163(1):62-7. PubMed ID: 16271957
    [Abstract] [Full Text] [Related]

  • 17. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A.
    Pathobiology; 2007 Nov 15; 74(2):97-114. PubMed ID: 17587881
    [Abstract] [Full Text] [Related]

  • 18. Realistic pathologic classification of acute myeloid leukemias.
    Arber DA.
    Am J Clin Pathol; 2001 Apr 15; 115(4):552-60. PubMed ID: 11293903
    [Abstract] [Full Text] [Related]

  • 19. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR, Ross CW, Finn WG, Schnitzer B, Singleton TP.
    Hum Pathol; 2000 Sep 15; 31(9):1051-4. PubMed ID: 11014570
    [Abstract] [Full Text] [Related]

  • 20. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.
    Terstappen LW, Safford M, Könemann S, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wörmann B.
    Leukemia; 1992 Jan 15; 6(1):70-80. PubMed ID: 1540262
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.